Sökresultat - "SGLT2 inhibitors"

A proposed computational workflow for bioinformatics-based drug repurposing: A case study of Canagliflozin

El-Nikhely, Nefertiti, El-Yazbi, Ahmed F.

2024 International Conference on Machine Intelligence and Smart Innovation (ICMISI)

Sotagliflozin: Two Birds with One Stone?

Requena-Ibáñez, Juan Antonio^{Aff1, IDs1055702507723z_cor1}, Kindberg, Kristine Mørk^{Aff2, Aff3}, Santos-Gallego, Carlos G., Zafar, M. Urooj, Badimon, Juan J.^{Aff1, IDs1055702507723z_cor2}

Nicht-nierenersatztherapiepflichtige chronische Nierenkrankheit in der Hausarztpraxis – Update der DEGAM-Leitlinie

Chronic kidney disease in general practice—update of the DEGAM guideline

Negnal, Martha^{Aff1, IDs44266025003563_cor1}, Kiel, Simone, Stracke, Sylvia, Mathias, Leonard, Mathias, Elizabeth, Uebel, Til, Baum, Erika, Fleig, Susanne, Kuhlmann, Martin K., Galle, Jan, Weinmann-Menke, Julia, Seffrin, Joachim, Weinreich, Thomas, Daschner, Michael, Gollasch, Maik, Hoffmann, Ute, Diehl, Annette, Chenot, Jean-François

The effect of SGLT2 inhibitors on hepatic steatosis detected by MRI-PDFF in patients with type 2 Diabetes mellitus and metabolic-associated steatotic liver disease

Amin, Mona Ahmed, Sadik, Noha Adly^{Aff1, IDs1173902503902w_cor1}, Saad, Hala Ahmed, Fawzy, Mohammed, Elsheimy, Hend Abdallah

Early Initiation of SGLT2 Inhibitors in Acute Heart Failure: a Focus on Diuresis and Renal Protection

Hammer, Andreas, Niessner, Alexander^{Aff1, IDs10557023075126_cor1}, Sulzgruber, Patrick

Treatment discontinuation among users of GLP-1 receptor agonists and SGLT2 inhibitors in a national population of individuals with type 2 diabetes

Lim, Carl-Emil^{Aff1, IDs0012502506439x_cor1}, Pasternak, Björn^{Aff1, Aff2}, Eliasson, Björn, Ueda, Peter

Impact of empagliflozin on cardiac structure and function assessed by echocardiography after myocardial infarction: a post-hoc sub-analysis of the emmy trial

Schwegel, Nora, Strohhofer, Christoph^Aff1, Kolesnik, Ewald^{Aff1, IDs00392024025231_cor1}, Oltean, Sabrina, Hüttmair, Alexander, Pipp, Christian, Benedikt, Martin, Verheyen, Nicolas, Gollmer, Johannes, Ablasser, Klemens, Wallner, Markus, Santner, Viktoria, Tripolt, Norbert, Pferschy, Peter, Zechner, Peter, Alber, Hannes, Siller-Matula, Jolanta M., Kopp, Kristen, Zirlik, Andreas, Aziz, Faisal, Sourij, Harald^Aff2, von Lewinski, Dirk^Aff1

Mechanistic insights and emerging therapeutic strategies targeting endothelial dysfunction in cardiovascular diseases: Mechanistic insights and emerging therapeutic strategies targeting endothelial dysfunction

Heo, Kyung-Sun^{Aff1, IDs12272025015424_cor1}, Phan, Lan Phuong, Le, Nhi Thi Thao, Jin, Yujin

Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Acute Coronary Syndrome

Song, Jiawei^{aff1, aff2, aff3}, Liu, Yanping^aff4, Xu, Yani^aff1, Hao, Panpan^{aff1, aff2}

New interpretation of diabetic nephropathy or diabetic kidney disease from kidney biopsy: review article

Ubara, Yoshifumi^{Aff1, IDs10157025026614_cor1}, Sawa, Naoki, Yamanouchi, Masayuki, Kono, Kei, Ohashi, Kenichi^{Aff2, Aff3}

The Effect of Glucosuria Induced by SGLT2 Inhibitors on Thiamine Levels in Patients with Diabetes Mellitus

Ozcetin, Merve, Bicer, Irem, Dizdar, Oguzhan Sıtkı^{Aff2, IDs44411024000018_cor1}

Generalizability and treatment with sodium-glucose co-trasporter-2 inhibitors (SGLT2i) among patients with type 2 diabetes: an assessment using an Italian primary care database

Antonazzo, Ippazio Cosimo^{Aff1, Aff2, Aff8}, Rozza, Davide, Cortesi, Paolo Angelo^{Aff1, Aff8}, Fornari, Carla^{Aff1, IDs00592024023591_cor1}, Zanzottera Ferrari, Elena, Paris, Claire, Eteve-Pitsaer, Caroline, Gnesi, Marco, Mele, Silvia, D’Amelio, Marco, Maurizi, Anna Rita, Palladino, Pasquale, Mantovani, Lorenzo Giovanni^{Aff1, Aff8}, Mazzaglia, Giampiero

SGLT2 inhibitors: how do they affect the cardiac cells

Erdogan, Betul Rabia, Arioglu-Inan, Ebru^{Aff2, IDs1101002405084z_cor1}

The use of beta-blockers for heart failure with reduced ejection fraction in the era of SGLT2 inhibitors – are we still afraid to up-titrate?

Rode, Fran^{Aff1, IDs00380025025257_cor1}, Pavlović, Nikola, Jordan, Ana, Radić, Marija, Lisičić, Ante, Tomić, Sanda Sokol, Kursar, Jelena, Manola, Šime, Jurin, Ivana

Efficacy and safety of SGLT2 inhibitors in the treatment of maturity-onset diabetes of the young (MODY): a case report and literature review

Bombonato, Michelle, Beccuti, Guglielmo, Benso, Andrea, Giannone, Beatrice, Bertaina, Silvana, Broglio, Fabio, Bioletto, Fabio^{Aff1, IDs42000025006328_cor1}

Rationale and Design of Prospective, Multicenter, Double-Arm Clinical Trial to Investigate the Efficacy of Tofogliflozin on Left Ventricular Diastolic Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes Mellitus (TOP-HFPEF Trial)

Ito, Shin^{Aff1, Aff2}, Nakajima, Yuri^Aff1, Fukuda, Hiroki, Izumi, Chisato, Nakazawa, Gaku, Yamashita, Hajime, Matsuhisa, Hideo, Inoko, Moriaki, Toyoda, Shigeru, Takiuchi, Shin, Kataoka, Toru, Izumiya, Yasuhiro, Abe, Yukio, Sozu, Takashi, Sakata, Yasushi, Emoto, Masanori, Inoue, Teruo, Kitakaze, Masafumi^{Aff16, Aff17, Aff18, IDs1055702407576y_cor1}

Advances in the Design of Novel Antidiabetic Agents Using In-silico Approaches

Jadhav, Sanket^Aff3, Yeram, Pranali^Aff3, Alavala, Rajasekhar Reddy^Aff3, Vora, Amisha^Aff3

Rao G., S.N. Koteswara, editor^Aff1, Alavala, Rajasekhar Reddy, editor^Aff2

Safety of SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists in US veterans with and without chronic kidney disease: a population-based study.

Narasaki, Yoko, Kovesdy, Csaba, You, Amy, Sumida, Keiichi, Mallisetty, Yamini, Surbhi, Satya, Thomas, Fridtjof, Amin, Alpesh, Streja, Elani, Kalantar-Zadeh, Kamyar, Rhee, Connie

application/pdf

Expanding therapeutic horizons: glucagon-like peptide-1 receptor agonists and sodium glucose transporter-2 inhibitors in poly cystic ovarian syndrome: a comprehensive review including systematic review and network meta-analysis of randomized clinical trials

Kannan Sridharan, Gowri Sivaramakrishnan

electronic resource

Visa

Position of SGLT2i in prediabetes: A systematic review of literature

Kaushik Biswas, Vijaya Bhaskar Reddy, Krishna Seshadri, Nitin Kapoor, Mala Dharmalingam, Thamburaj Anthuvan

electronic resource

Visa